Genomma Set for Weekly Decline on Tax Concern: Mexico City Mover

Genomma Lab Internacional SAB (LABB), a Mexican producer of over-the-counter drugs, headed to its biggest weekly drop since June on speculation the government may create new taxes for medicine under a fiscal overhaul.

Genomma Lab sank 0.5 percent to 28.67 pesos at 1:28 p.m. in Mexico City trading today, bringing the selloff to 4.4 percent this week, the most since the period ended June 21. The benchmark IPC index of 35 Mexican stocks rose 1.2 percent today, trimming its slump this week to 3.2 percent.

President Enrique Pena Nieto’s Institutional Revolutionary Party lifted its ban on members’ voting for taxes on food and medicine in March. While the government hasn’t yet announced details of the tax overhaul that Pena Nieto has pledged to pass this year, Finance Minister Luis Videgaray told reporters on Aug. 28 that the plan will be presented with the administration’s budget proposal by Sept. 8 at the latest.

“The market is finally pricing in the risks from the fiscal reform,” Aldo Miranda, a trader at Intercam Casa de Bolsa SA in Mexico City, said in a telephone interview.

Genomma Lab will be among the Mexican stocks most affected by the reform, he said.

To contact the reporters on this story: Julia Leite in New York at; Jonathan Levin in Mexico City at

To contact the editor responsible for this story: David Papadopoulos at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.